Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:


Articles on the impact, diagnosis and treatment of the novel coronavirus and COVID-19

BioKangtai Strikes Deal to Supply AstraZeneca's COVID-19 Vaccine to China

Fosun Doses 72 Subjects in China Trial of mRNA COVID-19 Vaccine

CanSino Publishes Positive Phase II Data on COVID-19 Vaccine

Sinopharm CNBG Starts Phase III Trial of COVID-19 Vaccine in Abu Dhabi

Fosun Approved to Start China Trials of mRNA COVID-19 Vaccine

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China